Stem cell medicine encounters the immune system (original) (raw)

• Clarke, D. L. et al. Generalized potential of adult neural stem cells. Science 288, 1660–1663 (2000).
  Article CAS PubMed Google Scholar
• Jiang, Y. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41–49 (2002).Multipotent adult progenitor cells can be isolated from non-haematopoietic bone-marrow cells, expanded for more than 80 population doublings and differentiated in vitro , at the single-cell level, to form the products of all three germ layers.
  Article CAS PubMed Google Scholar
• Thomson, J. A. et al. Embryonic stem-cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).A landmark paper describing, for the first time, the derivation of human embryonic stem (hES) cells.
  Article CAS PubMed Google Scholar
• Amit, M. et al. Clonally derived human embryonic stem-cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271–278 (2000).
  Article CAS PubMed Google Scholar
• Reubinoff, B. E., Pera, M. F., Fong, C. Y., Trounson, A. & Bongso, A. Embryonic stem-cell lines from human blastocysts: somatic differentiation in vitro. Nature Biotechnol. 18, 399–404 (2000).
  Article CAS Google Scholar
• Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154–156 (1981).
  Article CAS PubMed Google Scholar
• Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634–7638 (1981).
  Article CAS PubMed PubMed Central Google Scholar
• Pedersen, R. A. Embryonic stem cells for medicine. Sci. Am. 280, 68–73 (1999).
  Article CAS PubMed Google Scholar
• McLaren, A. Ethical and social considerations of stem-cell research. Nature 414, 129–131 (2001).
  Article CAS PubMed Google Scholar
• Kim, J. H. et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418, 50–56 (2002).
  Article CAS PubMed Google Scholar
• Bjorklund, L. M. et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl Acad. Sci. USA 99, 2344–2349 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• McDonald, J. W. et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nature Med. 5, 1410–1412 (1999).
  Article CAS PubMed Google Scholar
• Brustle, O. et al. Embryonic stem-cell-derived glial precursors: a source of myelinating transplants. Science 285, 754–756 (1999).
  Article CAS PubMed Google Scholar
• Soria, B. et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49, 157–162 (2000).
  Article CAS PubMed Google Scholar
• Lumelsky, N. et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389–1394 (2001).
  Article CAS PubMed Google Scholar
• Chinzei, R. et al. Embryoid body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes. Hepatology 36, 22–29 (2002).
  Article PubMed Google Scholar
• Min, J. Y. et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92, 288–296 (2002).
  Article PubMed Google Scholar
• Zhang, S. C., Wernig, M., Duncan, I. D., Brustle, O. & Thompson, J. A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nature Biotechnol. 19, 1129–1133 (2001).
  Article CAS Google Scholar
• Auchincloss, H. & Bonventre, J. V. Transplanting cloned cells into therapeutic promise. Nature Biotechnol. 20, 665–666 (2002).
  Article CAS Google Scholar
• Odorico, J. S., Kaufman, D. S. & Thomson, J. A. Multilineage differentiation from human embryonic stem-cell lines. Stem Cells 19, 193–204 (2001).
  Article CAS PubMed Google Scholar
• Clausen, H. & Hakomori, S. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox. Sang. 56, 1–20 (1989).
  Article CAS PubMed Google Scholar
• Ito, N. & Hirota, T. Histochemical and cytochemical localisation of blood-group antigens. Prog. Histochem. Cytochem. 25, 1–85 (1992).
  Article CAS PubMed Google Scholar
• Springer, G. F. & Horton, R. E. Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J. Clin. Invest. 48, 1280–1291 (1969).
  Article CAS PubMed PubMed Central Google Scholar
• Paul, L. C. & Baldwin, W. M. Humoral rejection mechanisms and ABO incompatibility in renal transplantation. Transplant Proc. 19, 4463–4467 (1987).
  CAS PubMed Google Scholar
• Cooper, D. K. Clinical survey of heart transplantation between ABO blood-group-incompatible recipients and donors. J. Heart Transplant. 9, 376–381 (1990).
  CAS PubMed Google Scholar
• Clayton, H. A., Swift, S. M., James, R. F., Horsburgh, T. & London, N. J. Human islet transplantation — is blood group compatibility important? Transplantation 56, 1538–1540 (1993).
  CAS PubMed Google Scholar
• Borderie, V. M., Lopez, M., Vedie, F. & Laroche, L. ABO antigen blood-group compatibility in corneal transplantation. Cornea 16, 1–6 (1997).
  CAS PubMed Google Scholar
• Draper, J. S., Pigott, C., Thomson, J. A. & Andrews, P. W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 200, 249–258 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Drukker, M. et al. Characterisation of MHC protein expression in human embryonic stem cells. Proc. Natl Acad. Sci. 99, 9864–9869 (2002).Human ES cells express low levels of MHC class I molecules and are MHC class II negative, even when cultured with IFN-γ.
  Article CAS PubMed PubMed Central Google Scholar
• Simpson, E. et al. Minor H antigens: genes and peptides. Eur. J. Immunogenet. 28, 505–513 (2001).
  Article CAS PubMed Google Scholar
• Lechler, R. I. & Batchelor, J. R. Restoration of immunogenicity to passenger-cell-depleted kidney allografts by the addition of donor-strain dendritic cells. J. Exp. Med. 155, 31–34 (1982).
  Article CAS PubMed Google Scholar
• Iwai, H. et al. Acceptance of murine thyroid allografts by pretreatment of anti-Ia antibody or anti-dendritic cell antibody in vitro. Transplantation 47, 45–49 (1989).
  Article CAS PubMed Google Scholar
• Bowan, K. M., Andrus, L. & Lafferty, K. J. Successful allotransplantation of mouse pancreatic islets to nonimmunosuppressed recipients. Diabetes 29, 98–104 (1980).
  Article Google Scholar
• Munsie, M. J. et al. Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic-cell nuclei. Curr. Biol. 10, 989–992 (2000).
  Article CAS PubMed Google Scholar
• Kawase, E., Yamazaki, Y., Yagi, T., Yanagimachi, R. & Pedersen, R. A. Mouse embryonic stem (ES) cell lines established from neuronal-cell-derived cloned blastocysts. Genesis 28, 156–163 (2000).References 34 and 35 established proof of principle of ES-cell derivation from cloned mammalian embryos.
  Article CAS PubMed Google Scholar
• Wakayama, T. et al. Differentiation of embryonic stem-cell lines generated from adult somatic cells by nuclear transfer. Science 292, 740–743 (2001).
  Article CAS PubMed Google Scholar
• Hochedlinger, K. & Jaenisch, R. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415, 1035–1038 (2002).
  Article CAS PubMed Google Scholar
• Rideout, W. M. 3rd, Hochedlinger, K., Kyba, M., Daley, G. Q. & Jaenisch, R. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109, 17–27 (2002).
  Article CAS PubMed Google Scholar
• Lanza, R. P. et al. Generation of histocompatible tissues using nuclear transplantation. Nature Biotechnol. 20, 689–696 (2002).
  Article CAS Google Scholar
• Cibelli, J. B. et al. Somatic-cell nuclear transfer in humans: pronuclear and early embryonic development. E-biomed. J. Regener. Med. 2, 25–31 (2001).A demonstration of arrested embryonic development after somatic-cell nuclear transfer to human oocytes.
  Article Google Scholar
• Mitalipov, S. M., Yeoman, R. R., Nusser, K. D. & Wolf, D. P. Rhesus monkey embryos produced by nuclear transfer from embryonic blastomeres or somatic cells. Biol. Reprod. 66, 1367–1373 (2002).
  Article CAS PubMed Google Scholar
• Opelz, G., Wujciak, T., Dohler, B., Scherer, S. & Mytilineos, J. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev. Immunogenet. 1, 334–342 (1999).
  CAS PubMed Google Scholar
• Petersdorf, E. W. et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N. Engl. J. Med. 345, 1794–1800 (2001).
  Article CAS PubMed Google Scholar
• Petersdorf, E. W. et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 89, 1818–1823 (1997).
  CAS PubMed Google Scholar
• Petersdorf, E. W. et al. Optimising outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 92, 3515–3520 (1998).
  CAS PubMed Google Scholar
• Baur, M. P., Neugebauer, M. & Albert, E. D. in Histocompatibility Testing (eds Albert, E. D., Baur, M. P. & Mayr, W. R.) 756–757 (Springer Verlag, 1984).
  Google Scholar
• Kollman, C. et al. Non-HLA barriers to unrelated donor stem-cell transplantation. Bone Marrow Transplant. 27, 581–587 (2001).
  Article CAS PubMed Google Scholar
• Shaw, B. E., Madrigal, J. A. & Potter, M. Improving the outcome of unrelated donor stem-cell transplantation by molecular matching. Blood Rev. 15, 167–174 (2001).
  Article CAS PubMed Google Scholar
• Patel, R. & Terasaki, P. I. Significance of the positive crossmatch test in kidney transplantaion: N. Engl. J. Med. 280, 735–739 (1969).
  Article CAS PubMed Google Scholar
• Itescu, S. et al. Performed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 98, 786–793 (1998).
  Article CAS PubMed Google Scholar
• Kung, L., Gourishankar, S. & Halloran, P. F. Molecular pharmacology of immunosupressive agents in relation to their clinical use. Curr. Opin. Organ Transplant. 5, 268–275 (2000).
  Article Google Scholar
• Gourishankar, S., Turner, P. & Halloran, P. New developments in immunosuppressive therapy in renal transplantation. Expert Opin. Biol. Ther. 2, 483–501 (2002).
  Article CAS PubMed Google Scholar
• Simon, D. M. & Levin, S. Infectious complications of solid organ transplantations. Infect. Dis. Clin. North Am. 15, 521–549 (2001).
  Article CAS PubMed Google Scholar
• Penn, I. Post-transplant malignancy: the role of immunosuppression. Drug. Safety 23, 101–113 (2000).
  Article CAS PubMed Google Scholar
• Mayer, A. D. et al. Multicentre randomised trial comparing tacrolimus (FK506) and cyclosporin in the prevention of renal allograft rejection. Transplantation 64, 436–443 (1997).
  Article CAS PubMed Google Scholar
• Zijlstra, M. et al. β2-microglobulin-deficient mice lack CD4-8+ cytolytic T cells. Nature 344, 742–746 (1990).
  Article CAS PubMed Google Scholar
• Grusby, M. J., Johnson, R. S., Papaioannou, V. E. & Glimcher, L. H. Depletion of CD4+ T cells in major histocompatibility complex class-II-deficient mice. Science 253, 1417–1420 (1991).
  Article CAS PubMed Google Scholar
• Vugmeyster, Y. et al. Major histocompatibility complex (MHC) class I KbDb−/− deficient mice possess functional CD8+ T cells and natural killer cells. Proc. Natl Acad. Sci. USA 95, 12492–12497 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Grusby, M. J. et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl Acad. Sci. USA 90, 3913–3917 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, R. S. et al. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of 'major histocompatibility complex-deficient' skin grafts>. Transplantation 63, 1123–1133 (1997).References 57 and 58 showed that mouse skin grafts deficient in MHC molecules are still rejected rapidly by allogeneic recipients.
  Article CAS PubMed Google Scholar
• van den Elsen, P. J., Gobin, S. J., van Eggermond, M. C. & Peijnenburg, A. Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics 48, 208–221 (1998).
  Article CAS PubMed Google Scholar
• Gobin, S. J., van Zutphen, M., Westerheide, S. D., Boss, J. M. & van den Elsen, P. J. The MHC-specific enhanceosome and its role in MHC class I and β(2)-microglobulin gene transactivation. J. Immunol. 167, 5175–5184 (2001).
  Article CAS PubMed Google Scholar
• Restifo, N. P. et al. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177, 265–272 (1993).
  Article CAS PubMed Google Scholar
• Cromme, F. V. et al. Loss of transporter protein, encoded by the TAP1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med. 179, 335–340 (1994).
  Article CAS PubMed Google Scholar
• Chen, H. L. et al. A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer. Nature Genet. 13, 210–213 (1996).
  Article CAS PubMed Google Scholar
• Hicklin, D. J. et al. β2-microglobulin mutations, HLA-class I antigen loss and tumor progression in melanoma. J. Clin. Invest. 101, 2720–2729 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Burgert, H. G. & Kvist, S. An adenovirus type 2 glycoprotein blocks cell-surface expression of human histocompatibility class I antigens. Cell 41, 987–997 (1985).
  Article CAS PubMed Google Scholar
• Früh, K. et al. A viral inhibitor of peptide transporters for antigen presentation. Nature 375, 415–418 (1995).
  Article PubMed Google Scholar
• Storkus, W. J., Howell, D. N., Salter, R. D., Dawson, J. R. & Cresswell, P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 138, 1657–1659 (1987).
  CAS PubMed Google Scholar
• Storkus, W. J., Alexander, J., Payne, J. A., Dawson, J. R. & Cresswell, P. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc. Natl Acad. Sci. USA 86, 2361–2364 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Zeidler, R. et al. Downregulation of TAP1 in B lymphocytes by cellular and Epstein–Barr virus-encoded interleukin-10. Blood 90, 2390–2397 (1997).
  CAS PubMed Google Scholar
• Bellgrau, D. et al. A role for CD95 ligand in preventing graft rejection. Nature 377, 630–632 (1995).
  Article CAS PubMed Google Scholar
• Strand, S. et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells — a mechanism of immune evasion? Nature Med. 2, 1361–1366 (1996).
  Article CAS PubMed Google Scholar
• Swenson, K. M. et al. Fas ligand gene transfer to renal allografts in rats: effects on allograft survival. Transplantation 65, 155–160 (1998).
  Article CAS PubMed Google Scholar
• Matsuda, M. et al. Interleukin-10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J. Exp. Med. 180, 2371–2376 (1994).
  Article CAS PubMed Google Scholar
• Qin, L. et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J. Immunol. 156, 2316–2323 (1996).
  CAS PubMed Google Scholar
• Lewandoski, M. Conditional control of gene expression in the mouse. Nature Rev. Genet. 2, 743–755 (2001).
  Article CAS PubMed Google Scholar
• Grey, S. T., Arvelo, M. B., Hasenkamp, W., Bach, F. H. & Ferran, C. A20 inhibits cytokine-induced apoptosis and nuclear factor-κB-dependent gene activation in islets. J. Exp. Med. 190, 1135–1146 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. & Lanier, L. L. Direct recognition of cytomegalovirus by activating and inhibitory NK-cell receptors. Science 296, 1323–1326 (2002).
  Article CAS PubMed Google Scholar
• Karim, M., Steger, U., Bushell, A. R. & Wood, K. J. The role of the graft in establishing tolerance. Front. Biosci. 7, e129–e154 (2002).
  Article CAS PubMed Google Scholar
• Wood, K. J., Jones, N. D., Bushell, A. R. & Morris, P. J. Alloantigen-induced specific immunological unresponsiveness. Philos. Trans. R. Soc. Lond. B 356, 665–680 (2001).
  Article CAS Google Scholar
• Knechtle, S. J., Hamawy, M. M., Hu, H., Fechner, J. H. & Cho, C. S. Tolerance and near-tolerance strategies in monkeys and their application to human renal transplantation. Immunol. Rev. 183, 205–213 (2001).
  Article CAS PubMed Google Scholar
• Fairchild, P. J. & Waldmann, H. Dendritic cells and prospects for transplantation tolerance. Curr. Opin. Immunol. 12, 528–535 (2000).
  Article CAS PubMed Google Scholar
• Coutinho, A., Hori, S., Carvalho, T. & Demengeot, J. Regulatory T cells: the physiology of autoreactivity in dominant tolerance and 'quality control' of immune responses. Immunol. Rev. 182, 89–98 (2001).
  Article CAS PubMed Google Scholar
• Sykes, M. Mixed chimerism and transplant tolerance. Immunity 14, 417–424 (2001).
  Article CAS PubMed Google Scholar
• Millan, M. T. et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 73, 1386–1391 (2002).
  Article PubMed Google Scholar
• Kaufman, D. S., Hanson, E. T., Lewis, R. L., Auerbach, R. & Thomson, J. A. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 98, 10716–10721 (2001).The first demonstration of haematopoietic-cell differentiation from hES cells.
  Article CAS PubMed PubMed Central Google Scholar
• Ilstad, S. T. & Sachs, D. H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307, 168–170 (1984).
  Article Google Scholar
• Ildstad, S. T., Wren, S., Bluestone, J. A., Barbieri, S. A. & Sachs, D. H. Characterisation of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity and genetic specificity of tolerance. J. Exp. Med. 162, 231–244 (1985).
  Article CAS PubMed Google Scholar
• Tomita, Y., Sachs, D. H. & Sykes, M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 83, 939–948 (1994).
  CAS PubMed Google Scholar
• Nikolic, B., Zhao, G., Swenson, K. & Sykes, M. A novel application of cyclosporin A in nonmyeloablative pretransplant host conditioning for allogeneic BMT. Blood 96, 1166–1172 (2000).
  CAS PubMed Google Scholar
• Wekerle, T. et al. Allogeneic bone-marrow transplantation with costimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nature Med. 6, 464–469 (2000).
  Article CAS PubMed Google Scholar
• Durham, M. M. et al. Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J. Immunol. 165, 1–4 (2000).
  Article CAS PubMed Google Scholar
• Fandrich, F. et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nature Med. 8, 171–178 (2002).Injection of pre-implantation-stage rat ES cells into the portal vein of allogeneic recipients leads to haematopoietic chimerism and long-term acceptance of an allogeneic cardiac allograft.
  Article CAS PubMed Google Scholar
• Khan, A., Tomita, Y. & Sykes, M. Thymic dependence of loss of tolerance in mixed allogeneic bone-marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 62, 380–387 (1996).
  Article CAS PubMed Google Scholar
• Tomita, Y., Khan, A. & Sykes, M. Role of intrathymic clonal deletion and peripheral anergy in transplant tolerance induced by bone-marrow transplantation in mice conditioned with a non-myeloablative regimen. J. Immunol. 153, 1087–1098 (1994).
  CAS PubMed Google Scholar
• Manilay, J. O., Pearson, D. A., Sergio, J. J., Swenson, K. G. & Sykes, M. Intrathymic deletion of alloreactive T cells in mixed bone-marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation 66, 96–102 (1998).
  Article CAS PubMed Google Scholar
• Wekerle, T. et al. Extrathymic T-cell deletion and allogeneic stem-cell engraftment induced with costimulatory blockade is followed by central T-cell tolerance. J. Exp. Med. 187, 2037–2044 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Kyba, M., Perlingeiro, R. C. & Daley, G. Q. HoxB4 confers definitive lymphoid–myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109, 29–37 (2002).The first demonstration of the derivation from mouse ES cells of haematopoietic stem cells with potential for multi-lineage long-term engraftment.
  Article CAS PubMed Google Scholar
• Solter, D. & Knowles, B. B. Immunosurgery of mouse blastocyst. Proc. Natl Acad. Sci. USA 72, 5099–5102 (1975).
  Article CAS PubMed PubMed Central Google Scholar
• Reubinoff, B. E., Pera, M. F., Fong, C. Y., Trounson, A. & Bongso, A. Embryonic stem-cell lines from human blastocysts: somatic differentiation in vitro. Nature Biotechnol. 18, 399–404 (2000).
  Article CAS Google Scholar
• Badcock, G., Pigott, C., Goepel, J. & Andrews, P. W. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan. Cancer Res. 59, 4715–4719 (1999).
  CAS PubMed Google Scholar
• Gould, D. S. & Auchincloss, H. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol. Today 20, 77–82 (1999).
  Article CAS PubMed Google Scholar
• Pietra, B. A., Wiseman, A., Bolwerk, A., Rizeq, M. & Gill, R. G. CD4 T-cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J. Clin. Invest. 106, 1003–1010 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Frasca, L. et al. Interferon-γ-treated renal tubular epithelial cells induce allospecific tolerance. Kidney Int. 53, 679–689 (1998).
  Article CAS PubMed Google Scholar
• Vella, J. P. et al. Cellular and humoral mechanisms of vascularised allograft rejection induced by indirect recognition of donor MHC allopeptides. Transplantation 67, 1523–1532 (1999).
  Article CAS PubMed Google Scholar
• Lee, R. S., Grusby, M. J., Glimcher, L. H., Winn, H. J. & Auchincloss, H. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med. 179, 865–872 (1994).
  Article CAS PubMed Google Scholar
• Steele, D. J. et al. Two levels of help for B-cell alloantibody production. J. Exp. Med. 183, 699–703 (1996).
  Article CAS PubMed Google Scholar